ResMed Inc. Files 8-K: Director Changes & Compensation Updates
Ticker: RSMDF · Form: 8-K · Filed: Aug 18, 2025 · CIK: 943819
| Field | Detail |
|---|---|
| Company | Resmed Inc (RSMDF) |
| Form Type | 8-K |
| Filed Date | Aug 18, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.004, $75,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, director-changes
TL;DR
ResMed filed an 8-K on 8/18/25 detailing director changes and executive pay adjustments.
AI Summary
ResMed Inc. filed an 8-K on August 18, 2025, reporting on the departure of a director, election of a new director, and changes in officer compensation arrangements. The filing also includes financial statements and exhibits. The report covers events as of August 15, 2025.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance and executive compensation matters, not significant financial or operational events.
Key Players & Entities
- RESMED INC (company) — Registrant
- August 15, 2025 (date) — Earliest event reported
- August 18, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 9001 Spectrum Center Blvd. San Diego, California 92123 (address) — Principal executive offices
FAQ
Who has departed from ResMed's board of directors?
The filing indicates the departure of a director, but the specific name is not provided in the excerpt.
Has a new director been elected to ResMed's board?
Yes, the filing states that a new director has been elected.
What other items are covered in this 8-K filing?
The filing also covers changes to compensatory arrangements of certain officers and includes financial statements and exhibits.
What is the earliest date for events reported in this filing?
The earliest event reported is dated August 15, 2025.
What is ResMed Inc.'s principal executive office address?
ResMed Inc.'s principal executive offices are located at 9001 Spectrum Center Blvd., San Diego, California 92123.
Filing Stats: 837 words · 3 min read · ~3 pages · Grade level 11.8 · Accepted 2025-08-18 16:20:28
Key Financial Figures
- $0.004 — nge on which registered Common Stock, $0.004 par value RMD NYSE Indicate by che
- $75,000 — ainer provision for fiscal year 2026 to $75,000 as approved by the board of directors i
Filing Documents
- d72598d8k.htm (8-K) — 29KB
- d72598dex991.htm (EX-99.1) — 8KB
- g72598dsp05.jpg (GRAPHIC) — 11KB
- 0001193125-25-182695.txt ( ) — 169KB
- rmd-20250815.xsd (EX-101.SCH) — 3KB
- rmd-20250815_lab.xml (EX-101.LAB) — 18KB
- rmd-20250815_pre.xml (EX-101.PRE) — 11KB
- d72598d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d)Exhibits Exhibits: Description of Document 99.1 Press Release dated August 18, 2025, regarding results of operations 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) -3-
SIGNATURES
SIGNATURES We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934. Date: August 18, 2025, RESMED INC. (registrant) By: /s/ Michael Rider Name: Michael Rider Its: Secretary -4-